Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- Congratulations Dr. Kim on new AAAHC leadership position (AGA)
- When RVUs Go Wrong: Red Flags for Physicians (Medscape)
- GI Side Effects of Immune Checkpoint Inhibitors Linked to Colon Adenoma Risk (GI & Hepatology News)
- Would You Track Your Stools Like You Track Your Steps? (Bloomberg)
- Good news, bad news for gastroenterology (Becker’s GI & Endoscopy)
- Addressing Colonoscopy Burden due to Artificial Intelligence Devices for Polyp Detection (Gastro Journal)
- Gastro Center of Maryland Expands to Bethesda and Silver Spring, Broadening Access to GI Care in the DMV (USA Today)
- To Improve CRC Screening in Patients Aged 45-49, Just Send Them a FIT Kit (GI & Endoscopy News)
